World Alzheimer's Day 2020: Ending The Stigma Around Dementia

Elsevier, 18th September 2020

World Alzheimer's Day is an international campaign organised by Alzheimer's Disease International to raise awareness and highlight issues faced by people affected by dementia. It takes place every year on September 21st and is the focus of World Alzheimer's Month.

Dementia is one of the biggest challenges we face, with nearly 50 million people living with dementia worldwide. Yet 2 out of every 3 people globally believe there is little or no understanding of dementia in their countries.The impact of World Alzheimer's Month is growing, but the stigmatisation and misinformation that surrounds dementia remains a global problem. To tackle this challenge, we need to collaborate and share best practice with one another.

In support of this year’s theme – ‘Let’s talk about dementia’ - Elsevier presents a curated, open access collection of 25 journal articles and book chapters focused on challenging the fear and stigma associated with dementia.

Together, we can help people live well with dementia.

Elsevier,

Journal of Aging Studies, Volume 48, March 2019, Pages 76-84

This article addresses goal 3 by discussing epistemic injustice experienced by people with dementia.
Elsevier,

Journal of Aging Studies, Volume 44, March 2018, Pages 45-51

This article addresses goal 3 by examining the importance of stigma in shaping the experiences of people living with dementia and challenging their social citizenship.
Elsevier,

Ageing Research Reviews, Volume 58, March 2020, 101003

This article addresses SDG 3 by examining change point modeling for cognitive aging research.
Elsevier,

Mechanisms of Ageing and Development, Volume 190, September 2020, 111290

This article addresses goal 3 by investigating FOXO3a as a potential blood biomarker for early detection of Alzheimer's Disease.
Elsevier,

Neurobiology of Disease, Volume 139, June 2020, 104810

This article addresses goal 3 by examining Cerebrospinal fluid and its potential use as a biomarker in Azheimer's Disease.
Elsevier,

Molecular and Cellular Neuroscience, Volume 97, June 2019, Pages 18-33

This article addresses goal 3 by examining tau biomarkers derived from neuroimaging and CSD for Alzheimer's Disease.
Elsevier,

Journal of Neuroscience Methods, Volume 337, 1 May 2020, 108669

This article addresses goal 3 by investigating the use of MRI for early Alzheimer's disease diagnosis.
Elsevier,

Neurobiology of Aging, Volume 88, April 2020, Pages 33-41

This article addresses goal 3 by investigating cognitive reserve and biomarkers of Alzheimer's Disease.
Elsevier,

Journal of Neuroscience Methods, Volume 327, 1 November 2019, 108388

This article addresses goal 3 by investigating the ability of 3D technology to aid research and diagnosis for mild cognitive impairment or dementia.
Elsevier,

The American Journal of Geriatric Psychiatry, Volume 26, Issue 3, March 2018, Pages 316-331

This article addresses goal 3 by discussing the stigma of Dementia and bringing light to this important issue.